HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,165.00
-10.00 (-0.24%)
At close: Mar 6, 2026
-9.26%
Market Cap 120.75B
Revenue (ttm) 129.68B
Net Income (ttm) -3.14B
Shares Out 30.00M
EPS (ttm) -104.67
PE Ratio 9.70
Forward PE n/a
Dividend 35.00 (0.84%)
Ex-Dividend Date Apr 2, 2026
Volume 76,693
Average Volume 124,016
Open 4,065.00
Previous Close 4,175.00
Day's Range 4,040.00 - 4,200.00
52-Week Range 3,825.00 - 5,420.00
Beta 0.84
RSI 37.49
Earnings Date Mar 11, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 341
Stock Exchange KOSDAQ
Ticker Symbol 052260
Full Company Profile

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.

Financial Statements

News

There is no news available yet.